Evidence map›Paper›PMID 42600662›Full record

ArticleThe Journal of biological chemistry2026

The integrated stress response kinase GCN2 prevents ZAKα-Dependent inflammatory hyperactivation in macrophages.

Rodrigo Dias Requião, Lincon Felipe Lima-Silva, Paulo Estevão, Webster Leonardo Guimarães Costa, Nicholas Camargo Zani, Israel Costa Vasconcelos, Ítalo Esposti Poly Silva, Teng Teng Xu, Heloísa Monteiro do Amaral Prado, Barbara Steigenberger and 3 more

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rodrigo Dias RequiãoDepartment of Genetics, Evolution, Microbiology and Immunology, Institute of Biology (IB), University of Campinas (UNICAMP), Campinas, Brazil; Department of Immunoregulation, Max Planck Institute of Biochemistry (MPIB), Max Planck Society (MPG), Martinsried, Germany. Electronic address: requiao@unicamp.br.
Lincon Felipe Lima-SilvaDepartment of Genetics, Evolution, Microbiology and Immunology, Institute of Biology (IB), University of Campinas (UNICAMP), Campinas, Brazil.
Paulo EstevãoDepartment of Genetics, Evolution, Microbiology and Immunology, Institute of Biology (IB), University of Campinas (UNICAMP), Campinas, Brazil.
Webster Leonardo Guimarães CostaDepartment of Genetics, Evolution, Microbiology and Immunology, Institute of Biology (IB), University of Campinas (UNICAMP), Campinas, Brazil.
Nicholas Camargo ZaniDepartment of Genetics, Evolution, Microbiology and Immunology, Institute of Biology (IB), University of Campinas (UNICAMP), Campinas, Brazil.
Israel Costa VasconcelosDepartment of Biochemistry and Tissue Biology, Institute of Biology (IB), University of Campinas (UNICAMP), Campinas, Brazil; Center for Medicinal Chemistry (CQMED), Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.
Ítalo Esposti Poly SilvaDepartment of Biochemistry and Tissue Biology, Institute of Biology (IB), University of Campinas (UNICAMP), Campinas, Brazil; Center for Medicinal Chemistry (CQMED), Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.
Teng Teng XuDepartment of Immunoregulation, Max Planck Institute of Biochemistry (MPIB), Max Planck Society (MPG), Martinsried, Germany.
Heloísa Monteiro do Amaral PradoDepartment of Biochemistry and Tissue Biology, Institute of Biology (IB), University of Campinas (UNICAMP), Campinas, Brazil.
Barbara SteigenbergerMax Planck Institute of Biochemistry Core Facility, Max Planck Society (MPG), Martinsried, Germany.
Mario Henrique BengtsonDepartment of Biochemistry and Tissue Biology, Institute of Biology (IB), University of Campinas (UNICAMP), Campinas, Brazil; Center for Medicinal Chemistry (CQMED), Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.
Peter J MurrayDepartment of Immunoregulation, Max Planck Institute of Biochemistry (MPIB), Max Planck Society (MPG), Martinsried, Germany.
Pedro M Moraes-VieiraDepartment of Genetics, Evolution, Microbiology and Immunology, Institute of Biology (IB), University of Campinas (UNICAMP), Campinas, Brazil; Experimental Medicine Research Cluster (EMCR), University of Campinas (UNICAMP), Campinas, Brazil. Electronic address: pmvieira@unicamp.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages orchestrate inflammation through rapid and extensive proteome remodeling, yet the translational programs governing macrophage activation remain poorly defined. Here, we show that classically activated macrophages (lipopolysaccharide + interferon-γ-treated) and alternatively activated macrophages (IL-4-treated) engage fundamentally distinct translational trajectories. Whereas alternatively activated macrophages sustain elevated protein synthesis, classically activated macrophages undergo a rapid but transient increase in translation that is subsequently restrained by the integrated stress response kinase General Control Nonderepressible 2 (GCN2). Using puromycin incorporation and quantitative proteomics, we demonstrate that GCN2-mediated phosphorylation of eukaryotic translation initiation factor 2α limits global translation and constrains the proinflammatory response. Genetic loss of GCN2 results in excessive translation and hyperinflammation driven by the ribosome-associated stress sensor ZAKα (Map3k20). Pharmacological inhibition of ZAKα in GCN2-deficient macrophages selectively normalizes tumor necrosis factor α secretion, establishing a functional regulatory axis in which GCN2 suppresses ZAKα-dependent inflammatory signaling. Together, these findings redefine translational control as a central checkpoint in macrophage activation, revealing how GCN2 mitigates ribosomal stress to prevent inflammatory hyperactivation, with potential therapeutic implications for tumor necrosis factor α -driven inflammatory diseases.

Indexed as

GCN2 signalinginflammation regulationmacrophage activationtranslation controlZAKα pathway

Identifiers

PMID42600662
PMCPMC13584029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.